Heidari R. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sci 2019; 218: 65-80.
2. Fayaz SM, Raj YV, Krishnamurthy RG. CypD: The key to the death door. CNS Neurol Disord Drug Targets 2015; 14: 654-663.
3. Prasad SK, Acharjee A, Singh VV, Trigun SK, Acharjee P. Modulation of brain energy metabolism in hepatic encephalopathy: Impact of glucose metabolic dysfunction. Metab Brain Dis 2024; 39: 1649-1665.
4. Coluccino G, Muraca VP, Corazza A, Lippe G. Cyclophilin D in mitochondrial dysfunction: A key player in neurodegeneration? Biomolecules 2023; 13: 1265:1-30
5. Dashzeveg N, Yoshida K. Cell death decision by p53 via control of the mitochondrial membrane. Cancer Lett 2015; 367: 108-112.
6. Kumarswamy R, Chandna S. Putative partners in Bax mediated cytochrome-c release: ANT, CypD, VDAC or none of them? Mitochondrion 2009; 9: 1-8.
7. Herzig S, Shaw RJ. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 2018; 19: 121-135.
8. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, et al. Sirtuin 3, a new target of PGC-1α, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010; 5: e11707.
9. Meng H, Yan WY, Lei YH, Wan Z, Hou YY, Sun LK, et al. SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases. Front Neurosci 2019; 11:313.
10. Sidorova-Darmos E, Sommer R, Eubanks J. The role of SIRT3 in the brain under physiological and pathological conditions. Front Cell Neurosci 2018; 12: 196.
11. Yang H, Zhou Z, Liu Z, Chen J, Wang Y. Sirtuin-3: A potential target for treating several types of brain injury. Front Cell Dev Biol 2023; 11:1154831.
12. Atlante A, Valenti D, Latina V, Amadoro G. Dysfunction of mitochondria in Alzheimer’s disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells. Int J Mol Sci 2022; 23: 7722.
13. Sharer JD. The adenine nucleotide translocase type 1 (ANT1): A new factor in mitochondrial disease. IUBMB Life 2005; 57: 607-614.
14. Argueti-Ostrovsky S, Barel S, Kahn J, Israelson A. VDAC1: A key player in the mitochondrial landscape of neurodegeneration. Biology (Basel) 2024; 15: 33.
15. Coluccino G, Negro A, Filippi A, Bean C, Muraca VP, Gissi C, et al. N-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthase. Commun Biol 2024; 7: 1486.
16. Shi W, Tan C, Liu C, Chen D. Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases. Rev Neurosci 2023; 34: 275-294.
17. Hao L, Shi M, Ma J, Shao S, Yuan Y, Liu J, et al. A cholecystokinin analogue ameliorates cognitive deficits and regulates mitochondrial dynamics via the AMPK/Drp1 pathway in APP/PS1 mice. CNS Neurosci Ther 2024; 11: 382-401
18. Li J, Wang Y, Wang Y, Wen X, Ma XN, Chen W, et al. Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction. Biochem Pharmacol 2015; 86: 62-74.
19. Guo X, Sesaki H, Qi X. Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo. Biochem J 2014; 461: 137-146.
20. Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves behavioral and biochemical deficits in hepatic encephalopathy induced by thioacetamide in rats. Neurosci Lett 2021; 745: 135617.
21. Nagi MN, Alam K, Badary OA, Al-Shabanah OA, Al-Sawaf HA, Al-Bekairi AM. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an anti-oxidant mechanism. IUBMB Life 1999; 47: 153-159.
22. Sedik AA, Hussein DT, Fathy K, Mowaad NA. Neuroprotective and cognitive enhancing effects of herbecetin against thioacetamide induced hepatic encephalopathy in rats via upregulation of AMPK and SIRT1 signaling pathways. Sci Rep 2024; 14: 11396.
23. Swapna I, Kumar KSS, Reddy PVB, Murthy CR, Reddanna P, Senthilkumaran B. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide. Neurochem Int 2006; 49: 238-244.
24. Butterworth RF. Hepatic encephalopathy: A central neuroinflammatory disorder? Hepatology 2011; 53:1372-1376.
25. Sathyasaikumar K, Swapna I, Reddy P, Murthy CR, Roy K, Gupta AD, et al. Co-administration of C-phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats. J Neurol Sci 2007; 252: 67-75.
26. Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves cognitive and hippocampal long-term potentiation deficits due to hepatic encephalopathy in rats. Iran J Basic Med Sci 2021; 24:881.
27. Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves behavioral and biochemical deficits in hepatic encephalopathy induced by thioacetamide in rats. Neurosci Lett 2021; 745:135617.
28. Chinopoulos C, Zhang SF, Thomas B, Ten V, Starkov AA. Isolation and functional assessment of mitochondria from small amounts of mouse brain tissue. In: Neurodegeneration: Methods and protocols. Springer; 2011. p. 311-324.
29. Lee DR, Helps SC, Macardle PJ, Nilsson M, Sims NR. Alterations in membrane potential in mitochondria isolated from brain subregions during focal cerebral ischemia and early reperfusion: evaluation using flow cytometry. Neurochem Res 2009; 34:1857-1866.
30. Caro AA, Adlong LW, Crocker SJ, Gardner MW, Luikart EF, Gron LU. Effect of garlic-derived organosulfur compounds on mitochondrial function and integrity in isolated mouse liver mitochondria. Toxicol Lett 2012; 214:166-174.
31. Niknahad H, Heidari R, Alzuhairi AM, Najibi A. Mitochondrial dysfunction as a mechanism for pioglitazone-induced injury toward HepG2 cell line. Pharm Sci 2014; 20:169-174.
32. Ghadernezhad N, Khalaj L, Pazoki-Toroudi H, Mirmasoumi M, Ashabi G. Metformin pretreatment enhanced learning and memory in cerebral forebrain ischaemia: The role of the AMPK/BDNF/P70SK signalling pathway. Pharm Biol 2016; 54:2211-2219.
33. Jalali MS, Saki G, Farbood Y, Saeed Azandeh S, Mansouri E, Dehcheshmeh MG, et al. Therapeutic effects of Wharton’s jelly-derived mesenchymal stromal cells on behaviors, EEG changes and IGF-1 in rat model of the Parkinson’s disease. J Chem Neuroanat 2021; 113:101921.
34. Dhanda S, Gupta S, Halder A, Sunkaria A, Sandhir R. Systemic inflammation without gliosis mediates cognitive deficits through impaired BDNF expression in bile duct ligation model of hepatic encephalopathy. Brain Behav Immun 2018; 70: 214-232.
35. Yan B, Liu Q, Ding X, Lin Y, Jiao X, Wu Y, et al. SIRT3-mediated CypD-K166 deacetylation alleviates neuropathic pain by improving mitochondrial dysfunction and inhibiting oxidative stress. Oxid Med Cell Longev 2022; 2022: 4722647.
36. Chadipiralla K, Reddanna P, Chinta RM, Reddy PVB. Thioacetamide-induced fulminant hepatic failure induces cerebral mitochondrial dysfunction by altering the electron transport chain complexes. Neurochem Res 2012; 37:59-68.
37. Jayakumar A, Panickar K, Murthy CR, Norenberg M. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci 2006; 26: 4774-4784.
38. Norenberg MD. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 2003; 37: 245-248.
39. Bustamante J, Lores-Arnaiz S, Tallis S, Roselló D, Lago N, Lemberg A, et al. Mitochondrial dysfunction as a mediator of hippocampal apoptosis in a model of hepatic encephalopathy. Mol Cell Biochem 2011; 354: 231-240.
40. Norenberg M, Rao KR. The mitochondrial permeability transition in neurologic disease. Neurochem Int 2007; 50: 983-997.
41. Przedborski S, Vila M. MPTP: A review of its mechanisms of neurotoxicity. J Neurochem 2001; 1: 407-418.
42. Dagon Y, Avraham Y, Ilan Y, Mechoulam R, Berry EM. Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J 2007; 21: 2431-2441.
43. Jafaripour L, Esmaeilpour K, Maneshian M, Bashiri H, Rajizadeh MA, Ahmadvand H, et al. The effect of gallic acid on memory and anxiety-like behaviors in rats with bile duct ligation-induced hepatic encephalopathy: role of AMPK pathway. Nutr Neurosci 2022; 12:425.
44. Anamika, Trigun SK. Sirtuin-3 activation by honokiol restores mitochondrial dysfunction in the hippocampus of the hepatic encephalopathy rat model of ammonia neurotoxicity. J Biochem Mol Toxicol 2021; 35: e22735.
45. Yang Y, Wang W, Tian Y, Shi J. Sirtuin 3 and mitochondrial permeability transition pore (mPTP): A systematic review. Mitochondrion 2022; 64:103-111.
46. Wang X, Gao X, Michalski S, Zhao S, Chen J. Traumatic brain injury severity affects neurogenesis in adult mouse hippocampus. J Neurotrauma 2016; 33: 721-733.
47. Ding W, Qi M, Ma L, Xu X, Chen Y, Zhang W, et al. ADP/ATP translocase 1 protects against an α-synuclein-associated neuronal cell damage in Parkinson’s disease model. Cell Death Dis 2021; 11:1-15.
48. Klumpe I, Savvatis K, Westermann D, Tschöpe C, Rauch U, Landmesser U, et al. Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress. J Mol Cell Cardiol 2016; 94: 645-653.
49. Zhang C, Jiang H, Wang P, Liu H, Sun X. Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions. Sci Rep 2017; 7: 44708.
50. Baek SH, Park SJ, Jeong JI, Kim SH, Han J, Kyung JW, et al. Inhibition of Drp1 ameliorates synaptic depression, Aβ deposition, and cognitive impairment in an Alzheimer’s disease model. J Neurosci 2017; 37: 5099-5110.
51. Song Y, Li T, Liu Z, Xu Z, Zhang Z, Chi L, et al. Inhibition of Drp1 after traumatic brain injury provides brain protection and improves behavioral performance in rats. Brain Res 2019; 304: 173-185.
52. . Du J, Li H, Song J, Wang T, Dong Y, Zhan A, et al. AMPK activation alleviates myocardial ischemia-reperfusion injury by regulating Drp1-mediated mitochondrial dynamics. Front Pharmacol 2022; 13:862204.
53. Yan X, Yang Y, Huang W, Fu S, Cui B, Chu M, et al. Beneficial effects of the herbal medicine Zuo Gui Wan in a mice model of Alzheimer’s disease via Drp1-mediated inhibition of mitochondrial fission and activation of AMPK/PGC-1α-regulated mitochondrial bioenergetics. J Ethnopharmacol 2025;119425.
54. Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, et al. Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. J Mol Cell Cardiol 2019; 53: 1-13.
55. Marchenko N, Moll U. Mitochondrial death functions of p53. Mol Cell Oncol 2014; 1: e955995.
56. Mukherjee R, Tetri LH, Li SJ, Fajardo G, Ostberg NP, Tsegay KB, et al. Drp1/p53 interaction mediates p53 mitochondrial localization and dysfunction in septic cardiomyopathy. J Mol Cell Cardiol 2023; 177: 28-37.
57. Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy. J Neuroinflammation 2020; 17: 1-11.
58. Milewski K, Orzeł-Gajowik K, Zielińska M. Mitochondrial changes in rat brain endothelial cells associated with hepatic encephalopathy: Relation to the blood-brain barrier dysfunction. Neurochem Res 2024; 49: 1489-1504.
59. Sun F, Si Y, Bao H, Xu S, Shi H, Zhang Y, et al. Regulation of sirtuin 3-mediated deacetylation of cyclophilin D attenuated cognitive dysfunction induced by sepsis-associated encephalopathy in mice. Cell Mol Neurobiol 2017; 37: 1457-1464.
60. Qi X, Qvit N, Su YC, Mochly-Rosen D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci 2013; 126:789-802.
61. Khanna A, Chakraborty S, Tripathi SJ, Acharjee A, Rao S, Trigun SK. SIRT1 activation by resveratrol reverses atrophy of apical dendrites of hippocampal CA1 pyramidal neurons and neurobehavioral impairments in moderate grade hepatic encephalopathy rats. J Chem Neuroanat 2020; 106:101797.
)